EW (NYSE: EW) Rule 144 filing details planned sale of 5,900 shares
Rhea-AI Filing Summary
EW filed a Rule 144 notice covering a proposed sale of 5,900 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $494,066.00. The notice states that there were 580,300,000 common shares outstanding at the time of the filing. The shares to be sold were originally acquired from the issuer between December 12, 2021 and May 8, 2022 through restricted stock vesting and option exercises under registered equity plans, all paid for in cash. The seller represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.
Positive
- None.
Negative
- None.
FAQ
How many EW shares are planned to be sold under this Rule 144 notice?
The notice covers a proposed sale of 5,900 shares of common stock of EW.
What is the aggregate market value of the EW shares in this planned Rule 144 sale?
The aggregate market value of the 5,900 EW common shares covered by the notice is $494,066.00.
On which exchange are the EW shares in this Rule 144 filing expected to be sold?
The EW common shares covered by the notice are expected to be sold on the NYSE.
When is the approximate sale date for the EW shares in this Rule 144 filing?
The notice lists an approximate date of sale of December 12, 2025 for the EW common shares.
How many EW shares were outstanding at the time referenced in this Rule 144 notice?
The notice states that there were 580,300,000 shares of EW common stock outstanding when the information was provided.
How were the EW shares in this Rule 144 filing originally acquired?
The shares were acquired from the issuer between December 12, 2021 and May 8, 2022 through restricted stock vesting under a registered plan and exercise of options under a registered plan, with payment made in cash.
Does the seller in this EW Rule 144 notice make any representation about material information?
Yes. The seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.